Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rai

Showing results (491-500 of 543) with videos related to

Pageof 55
Sort By:
The Journal of Clinical Investigation|November 23, 2021
B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemiaAndrea N Mazzarello, Eva Gentner-Göbel, Marcus Dühren-von Minden, et al.
The Journal of Clinical Investigation|February 16, 2005
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cellsBradley T Messmer, Davorka Messmer, Steven L Allen, et al.
Molecular Medicine (Cambridge, Mass.)|July 18, 2008
Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18)Brian A McCarthy, Erin Boyle, Xue Ping Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2025
Digital neuropathology of neurodegenerative disorders: Foundations, research advances, and future directionsAaron M Rosado, Juan C Vizcarra, Shivam R Rai Sharma, et al.
Haematologica|February 20, 2025
Chronic lymphocytic leukemia often arises by a multiclonal selection processDavide Bagnara, Andrea N Mazzarello, Niccolò Cardente, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft ModelShih-Shih Chen, Jacqueline C Barrientos, Gerardo Ferrer, et al.
Leukemia|January 28, 2021
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic targetFlorencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, et al.
Haematologica|November 8, 2011
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevancePreetesh Jain, Mohammad Javdan, Franziska K Feger, et al.
Molecular Medicine (Cambridge, Mass.)|November 15, 2008
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidationRosa Catera, Gregg J Silverman, Katerina Hatzi, et al.
Blood|June 26, 2008
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemiaLaura Z Rassenti, Sonia Jain, Michael J Keating, et al.
Pageof 55

Showing results (491-500 of 543) with videos related to

Sort By:
Pageof 55
The Journal of Clinical Investigation|November 23, 2021
B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemiaAndrea N Mazzarello, Eva Gentner-Göbel, Marcus Dühren-von Minden, et al.
The Journal of Clinical Investigation|February 16, 2005
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cellsBradley T Messmer, Davorka Messmer, Steven L Allen, et al.
Molecular Medicine (Cambridge, Mass.)|July 18, 2008
Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18)Brian A McCarthy, Erin Boyle, Xue Ping Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2025
Digital neuropathology of neurodegenerative disorders: Foundations, research advances, and future directionsAaron M Rosado, Juan C Vizcarra, Shivam R Rai Sharma, et al.
Haematologica|February 20, 2025
Chronic lymphocytic leukemia often arises by a multiclonal selection processDavide Bagnara, Andrea N Mazzarello, Niccolò Cardente, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft ModelShih-Shih Chen, Jacqueline C Barrientos, Gerardo Ferrer, et al.
Leukemia|January 28, 2021
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic targetFlorencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, et al.
Haematologica|November 8, 2011
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevancePreetesh Jain, Mohammad Javdan, Franziska K Feger, et al.
Molecular Medicine (Cambridge, Mass.)|November 15, 2008
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidationRosa Catera, Gregg J Silverman, Katerina Hatzi, et al.
Blood|June 26, 2008
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemiaLaura Z Rassenti, Sonia Jain, Michael J Keating, et al.
Pageof 55